Announcements Trials

Browse Landscape

Phase

Status

Completed 6 Not yet recruiting 2 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1 Hepatecellular Carcinoma 1 Colorectal Neoplasms 1

Interventions

Capecitabine 29 Oxaliplatin 28 Fluorouracil 16 Radiotherapy 15 Drug Therapy 11 Leucovorin 10 Bevacizumab 10 Surgical Procedures, Operative 9 Chemoradiotherapy 8 Radiation 7 sintilimab 6 Consolidation Chemotherapy 6 tislelizumab 5 spartalizumab 5 Specimen Handling 5 Irinotecan 5 Folfox protocol 5 trifluridine tipiracil drug combination 4 XELOX 4 Neoadjuvant Therapy 4 Endoscopy 4 Cetuximab 4 Biopsy 4 toripalimab 3 pembrolizumab 3 irinotecan sucrosofate 3 X-Rays 3 Radiotherapy, Intensity-Modulated 3 Proctectomy 3 Mastectomy, Segmental 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Rectal Neoplasms × raltitrexed × Clear all

NCT05628038 2024-10-01

TORCH-R

Fudan University

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡